Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Industry News

IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly

January 22, 2022

News Daily News

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

L.A. McKeown

August 21, 2020

News Daily News

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Yael L. Maxwell

June 18, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Industry News

Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon for a New Indication in Patients with End-Stage Renal Disease

January 30, 2017

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Conference News AHA 2013

Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients

Jason Kahn

November 17, 2013

Presentation TCT 2013

Renal Angioplasty And Stenting. Limitations. Role Of Embolic Protection Devices

Presenter: Isabelle Henry, Amira BENJELLOUN, Michel Henry

January 31, 2013

News Daily News

Meta-analysis: Renal Intervention Reduces BP Drugs, Not Outcomes

Caitlin E. Cox

March 18, 2011

Advertisement

Top Endovascular News of 2023

IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon for a New Indication in Patients with End-Stage Renal Disease

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients

Renal Angioplasty And Stenting. Limitations. Role Of Embolic Protection Devices

Meta-analysis: Renal Intervention Reduces BP Drugs, Not Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content